Enhanced Recovery After Surgery Program Ups Outcomes

Share this content:
Enhanced Recovery After Surgery Program Ups Outcomes
Enhanced Recovery After Surgery Program Ups Outcomes

FRIDAY, May 12, 2017 (HealthDay News) -- An enhanced recovery after surgery (ERAS) program is associated with improved outcomes for patients undergoing elective colorectal resection and emergency hip fracture repair, according to a study published online May 10 in JAMA Surgery.

Vincent X. Liu, M.D., from Kaiser Permanente in Oakland, Calif., and colleagues examined the outcomes of an ERAS program among 3,768 patients undergoing elective colorectal resection and 5,002 patients undergoing emergency hip fracture repair. A pre-post difference-in-differences study was conducted before and after ERAS implementation in the target populations, compared with contemporaneous surgical comparator groups (5,556 patients undergoing elective gastrointestinal surgery and 1,523 patients undergoing emergency orthopedic surgery).

The researchers observed significantly greater changes in the ERAS target populations in most process metrics after implementation compared with comparator surgical populations, including in ambulation, nutrition, and opioid use. After implementation, among ERAS target populations, hospital length of stay and postoperative complication rates were also significantly lower. The rate ratios for postoperative complications were 0.68 and 0.67 for patients undergoing colorectal resection and for patients with hip fracture, respectively. ERAS implementation correlated with decreased rate of hospital mortality among patients undergoing colorectal resection (0.17); implementation was associated with increased rates of home discharge among patients with hip fracture (1.24) .

"Rapid, large-scale implementation of a multidisciplinary ERAS program is feasible and effective in improving surgical outcomes," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »